Promoter collection, Human XPC promoter
Alternative name | U2751(2129)-1 |
---|---|
Clone info. | PCR amplified human XPC promoter sequence was inserted into a firefly luciferase vector. Cloned fragment: 14179875 to 14178575(NC_000003.12); relatively -1203 to +98, where +1 corresponds to 1 nt of NM_004628.4. |
Comment | PCR cloning, forward primer: ATGCACATGAAAAAGCCCTACT; reverse primer: TGTCTGGGCAAATTCCACTT. Entire sequence of promoter region has not been confirmed. |
Vector backbone | pGL4.10 [Luc2] (Plasmid) |
Selectable markers | Amp^r |
Gene/insert name | Human xeroderma pigmentosum, complementation group C genomic DNA |
Depositor|Developer | DNA Bank, | |
Remarks, protocol and/or map (pdf) | RDB07351.pdf |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 謝辞の表明を必要とする。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB07351 | pGL4-phXPC | DNA solution |
JPY 9,460 (not-for-profit academic purpose) plus cost of shipping containers, dry ice (if required) and shipping charge |
Materials & Methods section:
The pGL4-phXPC was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07351). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB07351_A4Kl.pdf ![]() |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: pGL4-4174F Sequence file: RDB07351_A4Kla.seq ![]() |
---|
>07351_07351_A4Kl_2_pGL4-4174F_D01_10.ab1 1 GTTGGGGTCC AGGAAATTTC TCTGGCCTAA CTGGCCGGTA CCTGAGCTCG CTAGCCTCGA 61 GGATATGCAC ATGAAAAAGC CCTACTGCTA CCTAAGCCTC TGTCTGGGAT GCCCACTGTC 121 TGCTCTTTTC ATCCTGTAGC TTTAAATATT GGCTTCTCAA AGAGGCTTCC TCTGATCATC 181 TAACTCATTC ACTCAAATAT TTTTTGAGTG TTTCCAGCAC TGTTCTAAAC CCCAAAGACA 241 AAAGAATGAA CAAAACAAAA TCCCTGCTCT TATGGCATTT ACATTCTAGT GGGGAGAGAT 301 TCACATTAAA CAAAGATGCA TACATTTAAT ATGAAAAAAT AACTCTCTAT GAAGAAAAAT 361 GAGGCAGGGT AACCAGAGTA GCGGGAGTGC TATTTGGGCA GAAGTCCTCT CTGAGGAGGT 421 CAGATTTCAG TAGAAAGTTT AAGTTGTGGC ATGATCTCCA AAGATATTTG AGGAAGAAAA 481 AGACCAGGTG AAAAAGCTTC TAGGACCATC TGTTATTCTG CATACCAGTT CCTTGTTTCC 541 TTCACAGCAC ATCACAGTTC CTGGAAGTCT TACATATTTA TATTTACTTT TATCTGTTCT 601 CCTCGCAAAT ATAAGCTCCA AGTAATGGCA AGGATCTCTT ATATGTCGAT GTCAGTGTCC 661 CTGGCCCTTA GAACAGTGCC TAACCATACA AAGCTGATGT TCACTCTATC TGCTGAATGA 721 ATAAATAATT GTTGCGCTCA CTAATGATAA CAACTCCTAA CTTTATTACC TGGCTTTCTA 781 TTGGAATCCT GACAGCTCCA TGAGGTAGCT AAGGATAATA ATCTACAGAT TTAAAAAAAT 841 GAAGCGAAGA GTGTGAGAAT AGTCATCAGG TGGGCTTCTA ACAGGAAAAG GTCTCAGGGC 901 CTACGGCAAA ATTCGGAGGG GGGGTTACGG AAAGGACAGG GTGGATTAGG CCATGGTGAC 961 TTGGAGAGAG GAGGCACGAC TGGCCATTTT TTCCTGAGTC TGGAAAAAAG CAGCCTAGTA 1021 CAAGAAAGCT TCCTTCGAGC GACCTCCTTT AAAAATACAC TTTACCCTTG GGTCTACGTC 1081 GTCGTCCATG ATTTCCAACC CTGCGTCCAT TCCCGGACTC TCGCGAAGAC ACAAGAAGCC 1141 AAACCGTCTC AAATC // |
Primer: pGL4-136R Sequence file: RDB07351_A4Klb.seq ![]() |
>07351_07351_A4Kl_2_pGL4-136R_G01_19.ab1 1 GGTTTCTAGG TTTTTTGGCA TCTTCCATGG TGGCTTTACC AACAGTACCG CGATTGCCAA 61 GCTTGGCCGC CGAGGCCAGA TCTTGATTGT CTGGGCAAAT TCCACTTGGC GAGTGACGCA 121 CCCGGCCGCG ATGCGCTAGA ACGCCGGCCC CGCCCCGAGG CGGTGCGCTT GGCCACGCCC 181 CTTCGTTGGA GGCCTAGTCA CGCCCCTAAA GGAAGCTCCA CCCCATACCC GTGGCCACTA 241 AAAAACTGCG GGAAGCAGGA AAGAGCACAA CAGGTTTCTC TCTATTTCCG GTGTATTGTA 301 TCCTCACGTT TCCGGAGATT GACGTTGCTC TTGTGTTCTC GCGAGAGGCG GGAAAGGGCG 361 CAGGGTTTGA AACATGGCGG ACGACGTAGA CCAGGTAAGT GTATTTTAAG GAGGTCGCTC 421 GAAGGAGCTT CTTGTACTAG GCTGCTTTTT CCAGACTCAG GAAAAATGGC CAGTCGTGCC 481 TCCTCTCTCC AAGTCACCAT GGCCTAATCC ACCCTGTCCT TTCCGTAACC CCCCCTCCGA 541 ATTTTGCCGT AGGCCCTGAG ACCTTTTCCT GTTAGAAGCC CACCTGATGA CTATTCTCAC 601 ACTCTTCGCT TCATTTTTTT AAATCTGTAG ATTATTATCC TTAGCTACCT CATGGAGCTG 661 TCAGGATTCC AATAGAAAGC CAGGTAATAA AGTTAGGAGT TGTTATCATT AGTGAGCGCA 721 ACAATTATTT ATTCATTCAG CAGATAGAGT GAACATCAGC TTTGTATGGT TAGGCACTGT 781 TCTAAGGGCC AGGGACACTG ACATCGACAT ATAGAGATCC TTGCCATTAC TTGAGCTTAT 841 ATTTGCGAGG AGAACAGAAT AAAAGTAAAT ATAAATATGT AAGACTTTCC AGGAACTGGT 901 GATGTGCTGT GAGGAAACAA GGACTGGTAT GCAGAATAAC AGAATGGTTC TTAGAGCTTT 961 CACCTTGTCT TTTTTCTTCC TCAAATTATC TTTGGGAAGA TCATGCACAA CCTTAACCTT 1021 TCTACTGGAA TCTGAACCTT CTCAGAGAGG AACTTCTTGC CAATAAGCAC TCTCGGCTAC 1081 CTTGTACCTG CTTCAATTCT CTAGAGTATT TCATTAAAGT GATGGCCACT TTGGTTAG // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content